This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
You too can leave a very important legacy for humanity
By bequeathing in favour of the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P CNIO) – Spain’s National Cancer Research Centre, recognised among the best in the world – you are contributing to the investigation of new treatments and drugs that cure cancer and new ways of early diagnosis for a disease that continues to be one of the leading causes of death in the world.
With your joint will you can contribute beyond your life to the health and well-being of people, without harming the rights of your legitimate heirs. You can have a great impact on people’s lives by further enabling the cancer research we do at the F.S.P CNIO, which ranges from the basic research of molecular mechanisms, to metastasis, or clinical research that enables the discoveries of our laboratories to reach patients as quickly as possible.
The Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P CNIO) is a foundation that is exempt from paying inheritance and donation taxes as it is governed by Law 49/2002, of December 23, regarding the tax regime of non-profit and non-profit entities and tax incentives for patronage. In other words, 100% of your inheritance or legacy will go entirely to cancer research.
If you want to formalize your greatest act of solidarity in favour of cancer research, please contact us and we will provide you with the necessary information to go to the notary.
We are at your disposal to clarify any questions by phone on 91 732 8000 or you can email us at: filantropia@cnio.es. We are available to speak to you in English or Spanish.
More information here
1. Is it convenient to make a will? 
Yes! It is a simple and affordable procedure that gives you legal certainty, avoiding future problems and you only pay the cost of the document.
In addition, you can include the F.S.P CNIO in your will respecting the percentage established by Spanish law, and therefore the rights of your legitimate heirs are also maintained.
As a reminder, if you do not make a will and you do not have heirs, all your assets will go to the State.
2. Decide what you would like to leave as a legacy
Depending on your circumstances and wishes, you can appoint the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P CNIO) as the universal heir to receive all of your assets, for the purposes of oncological research, or as joint heirs if your wish is for your assets to be distributed among several people or entities.
You can also leave us a legacy that is the donation of a specific asset, such as an amount of money, a property, or even designate the F.S.P CNIO as the beneficiary of your life insurance.
3. Write your will
Once you have decided what you wish to do with your assets, writing your will is the best way to ensure that your wishes will be fulfilled in the future. It the document that must respect current legislation, your notary will inform you and advise you on any legal issues.
Remember that you will have to provide our tax information to complete the process.
4. Inform us
If you decide to include the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P CNIO) in your will, we encourage you to contact us. First of all, we want to thank you for your generosity and trust. And second, because it is very important to guarantee the fulfilment of your will by providing the correct information to the notary.
We will treat any information with absolute confidentiality.
And finally, be proud, it is a valuable and important commitment. Your legacy will promote and enable cancer research within one of the world’s leading cancer research centres, providing an immeasurable positive impact on people’s lives by helping us stop cancer.